Tsuneo Takenaka

3.4k total citations
126 papers, 2.7k citations indexed

About

Tsuneo Takenaka is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Physiology. According to data from OpenAlex, Tsuneo Takenaka has authored 126 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Cardiology and Cardiovascular Medicine, 51 papers in Nephrology and 20 papers in Physiology. Recurrent topics in Tsuneo Takenaka's work include Blood Pressure and Hypertension Studies (38 papers), Renin-Angiotensin System Studies (21 papers) and Chronic Kidney Disease and Diabetes (18 papers). Tsuneo Takenaka is often cited by papers focused on Blood Pressure and Hypertension Studies (38 papers), Renin-Angiotensin System Studies (21 papers) and Chronic Kidney Disease and Diabetes (18 papers). Tsuneo Takenaka collaborates with scholars based in Japan, United States and Australia. Tsuneo Takenaka's co-authors include Hiromichi Suzuki, Tsutomu Inoue, Yoshihiko Kanno, Hirokazu Okada, Hiromichi Suzuki, H Förster, Murray Epstein, Takashi Miyazaki, Matsuhiko Hayashi and Yusuke Watanabe and has published in prestigious journals such as Journal of Clinical Investigation, Circulation Research and The Journal of Physiology.

In The Last Decade

Tsuneo Takenaka

121 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tsuneo Takenaka Japan 32 1.1k 990 614 491 359 126 2.7k
Nobuyuki Ura Japan 27 1.3k 1.2× 539 0.5× 551 0.9× 582 1.2× 754 2.1× 98 3.2k
Günter Wolf Germany 34 1.1k 1.0× 1.5k 1.5× 1.6k 2.5× 352 0.7× 722 2.0× 70 4.5k
Hans Herlitz Sweden 30 1.1k 1.0× 496 0.5× 428 0.7× 352 0.7× 745 2.1× 155 2.9k
Roland Willenbrock Germany 20 1.4k 1.3× 651 0.7× 597 1.0× 300 0.6× 600 1.7× 55 2.9k
Jan Menne Germany 23 1.6k 1.5× 701 0.7× 498 0.8× 240 0.5× 674 1.9× 59 3.0k
Jeffrey R. Schelling United States 36 469 0.4× 1.1k 1.1× 1.3k 2.1× 206 0.4× 458 1.3× 84 3.2k
Shunya Uchida Japan 33 443 0.4× 1.3k 1.3× 1.1k 1.8× 517 1.1× 400 1.1× 140 3.2k
Naoyuki Hasebe Japan 30 1.6k 1.5× 323 0.3× 887 1.4× 457 0.9× 265 0.7× 234 3.6k
Masato Kasahara Japan 28 807 0.7× 848 0.9× 791 1.3× 296 0.6× 402 1.1× 130 2.8k
Tetsuya Babazono Japan 33 649 0.6× 1.2k 1.3× 632 1.0× 333 0.7× 1.2k 3.2× 143 3.3k

Countries citing papers authored by Tsuneo Takenaka

Since Specialization
Citations

This map shows the geographic impact of Tsuneo Takenaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsuneo Takenaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsuneo Takenaka more than expected).

Fields of papers citing papers by Tsuneo Takenaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsuneo Takenaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsuneo Takenaka. The network helps show where Tsuneo Takenaka may publish in the future.

Co-authorship network of co-authors of Tsuneo Takenaka

This figure shows the co-authorship network connecting the top 25 collaborators of Tsuneo Takenaka. A scholar is included among the top collaborators of Tsuneo Takenaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsuneo Takenaka. Tsuneo Takenaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takenaka, Tsuneo, Hiroyuki Kobori, Naohito Ishii, et al.. (2024). Klotho supplementation decreases blood pressure and albuminuria in mice with lupus nephritis. European Journal of Pharmacology. 988. 177229–177229.
2.
Kawakami, Fumitaka, Yoshiko Iizuka, Kathrin Weyer, et al.. (2024). #1284 Proteinuria causes excessive proliferation and senescence in proximal tubular cells via receptor-mediated endocytosis. Nephrology Dialysis Transplantation. 39(Supplement_1). 1 indexed citations
3.
Takenaka, Tsuneo, Arif Ul Hasan, Takeshi Marumo, et al.. (2023). Klotho Supplementation Reverses Renal Dysfunction and Interstitial Fibrosis in Remnant Kidney. Kidney & Blood Pressure Research. 48(1). 326–337. 4 indexed citations
4.
Kawakami, Fumitaka, Motoshi Ouchi, Masanori Yokoba, et al.. (2022). In vitro study on effect of bardoxolone methyl on cisplatin-induced cellular senescence in human proximal tubular cells. Molecular and Cellular Biochemistry. 477(3). 689–699. 14 indexed citations
5.
Takenaka, Tsuneo, Hiroyuki Kobori, Tsutomu Inoue, et al.. (2020). Klotho supplementation ameliorates blood pressure and renal function in DBA/2-pcy mice, a model of polycystic kidney disease. American Journal of Physiology-Renal Physiology. 318(3). F557–F564. 21 indexed citations
6.
Takenaka, Tsuneo, et al.. (2018). Elevated pulse amplification in hypertensive patients with advanced kidney disease. Hypertension Research. 41(4). 299–307. 2 indexed citations
7.
Ohno, Yoichi, Takashi Miyazaki, Ryuichiro Araki, et al.. (2015). Lifestyle modifications supported by regional health nurses lowered insulin resistance, oxidative stress and central blood pressure in subjects with metabolic syndrome. Obesity Research & Clinical Practice. 9(6). 584–591. 5 indexed citations
8.
Takenaka, Tsuneo, Tsutomu Inoue, & Yusuke Watanabe. (2015). How the kidney hyperfiltrates in diabetes: From molecules to hemodynamics. World Journal of Diabetes. 6(4). 576–576. 10 indexed citations
9.
Takenaka, Tsuneo, et al.. (2013). Aliskiren Reduces Morning Blood Pressure in Hypertensive Patients with Diabetic Nephropathy on Hemodialysis. Clinical and Experimental Hypertension. 35(4). 244–249. 3 indexed citations
10.
Takenaka, Tsuneo, et al.. (2012). Aliskiren Reduces Morning Blood Pressure in Hypertensive Patients with Diabetic Nephropathy. Clinical and Experimental Hypertension. 34(4). 243–248. 6 indexed citations
11.
Kobayashi, Kazuhiro, Yoichi Ohno, Tsuneo Takenaka, et al.. (2011). Telmisartan Lowers Home Blood Pressure and Improves Insulin Resistance Without Correlation Between Their Changes. Clinical and Experimental Hypertension. 33(2). 100–105. 8 indexed citations
12.
Takenaka, Tsuneo, et al.. (2010). Seasonal Variations of Daily Changes in Blood Pressure Among Hypertensive Patients with End-Stage Renal Diseases. Clinical and Experimental Hypertension. 32(4). 227–233. 15 indexed citations
13.
Suzuki, Hiromichi & Tsuneo Takenaka. (2010). [Recent clinical evidences of RAS inhibitors on chronic kidney diseases].. PubMed. 52(2). 120–4. 2 indexed citations
14.
Miyazaki, Takashi, Tsuneo Takenaka, & Tsutomu Inoue. (2009). Zinc Deficiency may Accelerate Aging by Inhibiting Klotho mRNA Expression. 26. 74–78. 4 indexed citations
15.
Takenaka, Tsuneo, Tomohiro Kikuta, Tsutomu Inoue, et al.. (2009). Time for Reflection Predicts the Progression of Renal Dysfunction in Patients with Nondiabetic Chronic Kidney Disease. Clinical and Experimental Hypertension. 31(3). 220–230. 9 indexed citations
16.
Inoue, Tsutomu, Hirokazu Okada, Tsuneo Takenaka, Yusuke Watanabe, & Hiromichi Suzuki. (2009). A case report suggesting the occurrence of epithelial–mesenchymal transition in obstructive nephropathy. Clinical and Experimental Nephrology. 13(4). 385–388. 14 indexed citations
17.
Takenaka, Tsuneo, et al.. (2007). Vascular compliance is secured under angiotensin inhibition in non-diabetic chronic kidney diseases. Journal of Human Hypertension. 22(1). 38–47. 23 indexed citations
18.
Takenaka, Tsuneo, et al.. (2005). Comparison of changes in pulse wave velocity in patients on continuous ambulatory peritoneal dialysis and hemodialysis one year after introduction of dialysis therapy.. PubMed. 21. 139–45. 12 indexed citations
19.
Takenaka, Tsuneo, et al.. (2002). Oxidized low density lipoprotein (Ox-LDL) as a marker of atherosclerosis in hemodialysis (HD) patients. Clinical Nephrology. 58(7). 33–37. 44 indexed citations
20.
Okada, Hirokazu, Kenshi Moriwaki, Raghu Kalluri, et al.. (2000). Osteopontin expressed by renal tubular epithelium mediates interstitial monocyte infiltration in rats. American Journal of Physiology-Renal Physiology. 278(1). F110–F121. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobuyuki Ura Breakdown of academic impact, for papers by Günter Wolf Breakdown of academic impact, for papers by Hans Herlitz Breakdown of academic impact, for papers by Roland Willenbrock Breakdown of academic impact, for papers by Jan Menne Breakdown of academic impact, for papers by Jeffrey R. Schelling Breakdown of academic impact, for papers by Shunya Uchida Breakdown of academic impact, for papers by Naoyuki Hasebe Breakdown of academic impact, for papers by Masato Kasahara Breakdown of academic impact, for papers by Tetsuya Babazono
Rankless by CCL
2026